Photoinduced dermatitis and oral lichenoid reaction in a chronic myeloid leukemia patient treated with imatinib mesylate

Photodermatology Photoimmunology and Photomedicine

Volumn 28, Issue 1, 2012, Pages 2-5

  Brazzelli, Valeria ^a   Muzio, Francesca ^a   Manna, Giambattista ^a   Moggio, Erica ^a   Vassallo, Camilla ^a   Orlandi, Ester ^a   Fiandrino, Giacomo ^a   Lucioni, Marco ^a   Borroni, Giovanni ^a  

^a UNIVERSITY OF PAVIA   (Italy)

Author keywords

Chronic myeloid leukemia; Imatinib mesylate; Oral lichenoid eruption; Photoinduced dermatitis

Indexed keywords

BETAMETHASONE; BETAMETHASONE VALERATE; CYTARABINE; HYDROXYUREA; IMATINIB; PREDNISONE; STEROID;

ADULT; ARTICLE; CASE REPORT; CHRONIC MYELOID LEUKEMIA; DERMATITIS; DRUG WITHDRAWAL; ERYTHEMA; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LICHENOID; MOUTH CAVITY; ORAL LICHENOID REACTION; PHOTOINDUCED DERMATITIS; PRIORITY JOURNAL; RELAPSE; SKIN BIOPSY; TONGUE;

EID: 84855162303     PISSN: 09054383     EISSN: 16000781     Source Type: Journal    
DOI: 10.1111/j.1600-0781.2011.00621.x     Document Type: Article

References (10)

1. Brazzelli V, Prestinari F, Barbagallo T etal. A long-term time course of colorimetric assessment of the effects of imatinib mesylate on skin pigmentation: a study of five patients. J Eur Acad Dermatol Venereol 2007; 21: 384-387.
2. Valeyrie L, Bastuji-Garin S, Revuz J etal. Adverse cutaneous reactions to imatinib (STI571) in Philadelphia chromosome-positive leukemias: a prospective study of 54 patients. J Am Acad Dermatol 2003; 48: 201-206.
3. Peggs K, Mackinnon S. Imatinib mesylate - the new gold standard for treatment of chronic myeloid leukemia. N Engl J Med 2003; 348: 1048-1050.
4. Druker BJ, Talpaz M, Resta DJ etal. Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukaemia. N Engl J Med 2001; 344: 1031-1037.
5. Brazzelli V, Prestinari F, Roveda E etal. Pityriasis rosea-like eruption during treatment with imatinib mesylate: description of 3 cases. J Am Acad Dermatol 2005; 53: S240-S243.
6. Cario-Andrè M, Ardilouze L, Pain C, Gauthier Y, Mahon FX, Taieb A. Imatinib mesilate inhibits melanogenesis in vitro. Br J Dermatol 2006; 155: 477-500.
7. Brazzelli V, Roveda E, Prestinari F etal. Vitiligo-like lesions and diffuse lightening of the skin in a pediatric patient treated with imatinib mesylate: a noninvasive colorimetric assessment. Pediatr Dermatol 2006; 23: 175-178.
8. Tamura A, Onishi Y, An R. etal. In vitro evaluation of photosensitivity risk related to genetic polymorphisms of human ABC transporter ABCG2 and inhibition by drugs. Drug Metab Pharmacokinet 2007; 22: 428-440.
9. Lim DS, Muir J. Oral lichenoid reaction to imatinib (STI571, Gleevec). Dermatology 2002; 205: 168-171.
10. Ena P, Chiarolini F, Siddi GM, Cossu A. Oral lichenoid eruption secondary to imatinib (Glivec®). J Dermatolog Treat 2004; 15: 253-255.